CDK

FILTER BY:

Shopping Options

Actions
  1. Inhibitor (96)
  2. Agonist (1)
  3. Degrader (1)
Target
  1. Aurora A (1)
  2. Aurora B (1)
  3. CDK (3)
  4. CDK4 (2)
  5. FLT3 (3)
  6. JAK2 (2)
Catalog No.Inhibitor Name CDK1CDK2CDK3CDK4CDK5CDK6CDK7CDK8CDK9CLKCDKCdcOther
A10701Palbociclib HCl
****
***
A10806Roscovitine
*
**
*
ERK2,GST-ERK1,ERK1
A10850SNS-032
*
***
*
*
**
****
GSK-3α,GSK-3β
A11129Dinaciclib
****
****
****
****
A10390Flavopiridol
***
***
***
**
*
A10093AT7519
**
**
**
***
**
*
****
GSK-3β
A11045Flavopiridol HCl
***
***
*
***
***
*
A10494JNJ-7706621
****
****
*
**
Aurora A,Aurora B,VEGFR2
A11105AZD5438
***
****
**
***
A11167MK-8776
**
Chk1,Chk2
A10716PHA-793887
**
****
**
****
****
**
GSK-3β
A10163BS-181 HCl
***
A13811Palbociclib Isethionate
****
***
A11034A-674563
**
Akt1,PKA,GSK-3β
A16386abemaciclib
****
****
A11154BMS-265246
****
****
**
A11164PHA-767491
**
**
*
***
****
****
GSK-3β,MK2,PLK1
A11047Milciclib
*
***
**
*
**
TrkA
A11190R547
****
****
****
GSK-3β
A14136NU6027
*
*
ATR,DNA-PK
A13547P276-00
**
**
**
*
*
***
GSK-3β,PKCα,c-Src
A11220Kenpaullone
*
*
*
GSK-3β,ERK2,c-Src
A15889K03861
****
A14192THZ1
****
A11313AT7519 HCl
**
**
*
**
***
**
*
****
GSK-3β
A15517Purvalanol A
***
*
****
A14437Ro-3306
***
PKCδ,SGK,ERK
A14318SU9516
***
***
**
PDGFR
A13677XL413
****
****
Pim1,CK2
A14273LDC000067
*
*
*
***
A14297ML167
**
A13721TG003
***
A13549Ribociclib
A12216Wogonin
A10471Indirubin
*
GSK-3β
A11347CGP60474
***
***
PKCα
A12352Purvalanol B
****
****
A12438NU 6102
***
****
*
A12989LY2835219 (abemaciclib)
****
***
A14025AMG-925
*
****
FLT3
A15054CVT 313
*
*
*
A15196NVP-LCQ195
****
***
****
CHK2
A15767NU2058
*
*
DNA topoisomerase II ATPase
A15823LY2857785
*
***
***

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Items 1 to 50 of 97 total

per page
Page:
  1. 1
  2. 2

Set Descending Direction
  1. NU6300

    Catalog No. A21025
    Quick View
    ATP-competitive CDK2 inhibitor
    NU6300 is the first covalent ATP-competitive CDK2 inhibitor. Learn More
  2. Voruciclib hydrochloride

    Catalog No. A21385
    Quick View
    CDK inhibitor
    Voruciclib hydrochloride is a clinical stage orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. Learn More
  3. PHA-767491 hydrochloride

    Catalog No. A21395
    Quick View
    dual Cdc7/Cdk9 inhibitor
    PHA-767491 hydrochloride is a dual Cdc7/Cdk9 inhibitor, with IC50s of 10 nM and 34 nM, respectively. Learn More
  4. CDKI-73

    Catalog No. A21467
    Quick View
    CDK9 inhibitor
    CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM). Learn More
  5. CDK9-IN-1

    Catalog No. A21552
    Quick View
    CDK9 inhibitor
    CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. Learn More
  6. (±)-BAY-1251152

    Catalog No. A21564
    Quick View
    PTEF/CDK9 inhibitor
    (±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. Learn More
  7. (-)-BAY-1251152

    Catalog No. A21570
    Quick View
    PTEF/CDK9 inhibitor
    (-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. Learn More
  8. Lerociclib dihydrochloride

    Catalog No. A21577
    Quick View
    CDK4/CDK6 inhibitor
    Lerociclib dihydrochloride (G1T38 dihydrochloride) is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 1 nM and 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively. Learn More
  9. LDC4297

    Catalog No. A21613
    Quick View
    CDK7 inhibitor
    LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM. Learn More
  10. BS-181 hydrochloride

    Catalog No. A21988
    Quick View
    CDK7 inhibitor
    BS-181 hydrochloride is a highly selective CDK7 inhibitor with IC50 of 21 nM, and > 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9. Learn More
  11. SEL120-34A HCl

    Catalog No. A21485
    Quick View
    CDK8 inhibitor
    SEL120-34A HCl is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity. Learn More
  12. Senexin A

    Catalog No. A21166
    Quick View
    CDK8 inhibitor
    Senexin A is a CDK8 inhibitor with an IC50 of 280 nM. Learn More
  13. CDK-IN-2

    Catalog No. A11353
    Quick View
    CDK9 inhibitor
    CDK-IN-2 is a potent and specific CDK9 inhibitor with IC50 of <8 nM, extracted from reference 1, example 4. Learn More
  14. CDK8-IN-1

    Catalog No. A12961
    Quick View
    CDK8 inhibitor
    CDK8-IN-1 is a potent and selective CDK8 inhibitor with an IC50 of 3 nM. Learn More
  15. LY2835219 (abemaciclib)

    Catalog No. A12989
    Quick View
    CDK4/6 inhibitor
    LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. Learn More
  16. BMS-863233 (XL-413)

    Catalog No. A13677
    Quick View
    CDK inhibitor
    BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. Learn More
  17. P276-00

    Catalog No. A13547
    Quick View
    CDK Inhibitor
    P276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively. In Phase 2/3 Learn More
  18. LEE011 (Ribociclib)

    Catalog No. A13549
    Quick View
    CDK4/6 inhibitor
    LEE011 is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. Learn More
  19. LDC000067

    Catalog No. A14273
    Quick View
    CDK inhibitor
    LDC000067 is a highly selective CDK9 inhibitor . Learn More
  20. AMG-925

    Catalog No. A14025
    Quick View
    Dual FLT3/CDK4 inhibitor
    AMG-925 is a potent, selective, and bioavailable FLT3/cyclin-dependent kinase 4 (CDK4) dual kinase inhibitor. Learn More
  21. CVT-313

    Catalog No. A15054
    Quick View
    CDK2 Inhibitor
    CVT-313 is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 (IC50 = 0.5 uM for Cdk2/A and Cdk2/E; 4.2 uM for Cdk1/B; 215 uM for Cdk4/D1). Learn More
  22. Purvalanol A

    Catalog No. A15517
    Quick View
    CDK inhibitor
    Purvalanol A is a potent, cell-permeable cyclin-dependent protein kinase (cdk) inhibitor. IC50 values are 4, 70, 35, 850 and 75 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively. Learn More
  23. NVP-LCQ195

    Catalog No. A15196
    Quick View
    CDK inhibitor
    NVP-LCQ195 is a small molecule heterocyclic inhibitor of CDK1, CDK2, CDK3 and CDK5 with IC50 of 1-42 nM. Learn More
  24. AG-024322

    Catalog No. A15485
    Quick View
    CDK inhibitor
    AG-24322 is a second generation CDK inhibitor. AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclinical models. Learn More
  25. NU2058

    Catalog No. A15767
    Quick View
    CDK inhibitor
    NU2058 is a guanine-based CDK inhibitor with IC50 of 17 uM and 26 uM for CDK2 and CDK1. Learn More
  26. Bohemine

    Catalog No. A15942
    Quick View
    CDK inhibitor
    Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inhibitor with IC50 = 1 ,M. Learn More
  27. LY-3177833

    Catalog No. A16325
    Quick View
    CDC7 inhibitor
    LY-3177833 is a potent and selective inhibitor of CDC7 (Cell Division Cycle 7-related Protein Kinase). Learn More
  28. LY2835219 methanesulfonate

    Catalog No. A16386
    Quick View
    CDK4/6 inhibitor
    LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively. Phase 3. Learn More
  29. SB1317 (TG02)

    Catalog No. A13454
    Quick View
    CDK/JAK2/FLT3 inhibitor
    SB1317 is a potent inhibitor of Cyclin dependent kinases (CDKs), FMS-like tyrosine kinase-3 (FLT3) and Janus kinase 2 (JAK2) with IC50 values of 13nM, 56nM and 73nM for CDK2, JAK2 and FLT3, respectively. Learn More
  30. Atuveciclib (BAY-1143572)

    Catalog No. A16810
    Quick View
    Selective PTEFb/CDK9 inhibitor
    Atuveciclib, also known as BAY1143572, is a highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I. Learn More
  31. ICEC0942 HCl

    Catalog No. A16903
    Quick View
    CDK7 inhibitor
    ICEC0942, also known as CT7001, is an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. It selectively inhibits CDK7, with an IC50 of 40nM; IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. Learn More
  32. PF-06873600

    Catalog No. A16875
    Quick View
    CDK inhibitor
    PF-06873600 is an orally bioavailable, cyclin-dependent kinase (CDK) inhibitor, with potential antineoplastic activity. Learn More
  33. K03861

    Catalog No. A15889
    Quick View
    CDK inhibitor
    K03861 is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely. Learn More
  34. Palbociclib

    Catalog No. A14427
    Quick View
    CDK inhibitor
    Palbociclib is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Learn More
  35. ON123300

    Catalog No. A12584
    Quick View
    CDK4 inhibitor‎
    ON123300 is a potent multikinase inhibitor and may be potential useful for brain tumor chemotherapy. ON123300 strongly inhibits Ark5 and CDK4, as well as growth factor receptor tyrosine kinases such as ??-type platelet-derived growth factor receptor (PDGFR??). Learn More
  36. RGB-286638

    Catalog No. A13130
    Quick View
    CDK inhibitor
    RGB-286638 is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6. Learn More
  37. LY2857785

    Catalog No. A15823
    Quick View
    CDK9 inhibitor
    LY2857785 is a potent and selective CDK9 inhibitor; significantly reduces RNAP II CTD phosphorylation and dramatically decreases MCL1 protein levels to result in apoptosis in a variety of leukemia and solid tumor cell lines. Learn More
  38. NG52

    Catalog No. A12494
    Quick View
    Cell cycle-regulating kinase inhibitor
    NG52 is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 _mu_M), and the related Pho85p kinase (IC50 = 2 _mu_M). Learn More
  39. AT7519 trifluoroacetate

    Catalog No. A15005
    Quick View
    CDK inhibitor
    AT7519 trifluoroacetate is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM, less potent to CDK3 and little active to CDK7. Learn More
  40. CDK9 inhibitor 2

    Catalog No. A15039
    CDK9 inhibitor
    CDK9-IN-2 is a novel cyclin-dependent kinase 9(CDK9) inhibitor. Learn More
  41. NSC 663284

    Catalog No. A13524
    Quick View
    Cdc25 inhibitor
    NSC 663284 is a potent, cell-permeable, and irreversible inhibitor of all Cdc25 isoforms, with preference for Cdc25A (IC50 = 29, 95, and 89 nM for Cdc25A, Cdc25B2, and Cdc25C, respectively). Learn More
  42. AZD5597

    Catalog No. A13506
    Quick View
    CDK inhibitor
    AZD5597 is potent CDK inhibitor with in vitro anti-proliferative effects against a range of cancer cell lines. Learn More
  43. SEL120-34A

    Catalog No. A17086
    Quick View
    CDK8 inhibitor
    SEL120-34A is a potent and selective CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. Learn More
  44. Trilaciclib

    Catalog No. A17084
    Quick View
    CDK4/6 inhibitor
    Trilaciclib is a potential first-in-class short-acting CDK4/6 inhibitor in development to preserve hematopoietic stem cells and enhance immune system function during chemotherapy. Learn More
  45. FN-1501

    Catalog No. A13559
    Quick View
    FLT3/CDK inhibitor
    FN-1501 is a potent inhibitor of FLT3 and CDK, with IC50s of 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively. FN-1501 has anticancer activity. Learn More
  46. MSC2530818

    Catalog No. A12644
    Quick View
    CDK8 inhibitor
    MSC2530818 is a potent, selective and orally available CDK8 inhibitor with an IC50 of 2.6 nM for CDK8. Learn More
  47. Abemaciclib Metabolites M2

    Catalog No. A18416
    Quick View
    CDK4/CDK6 inhibitor
    Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s in the range of 1-3 nM. Anti-cancer activity. Learn More
  48. CDK2-IN-4

    Catalog No. A18667
    Quick View
    CDK2 inhibitor
    CDK2-IN-4 is a potent and selective CDK2 inhibitor with an IC50 of 44 nM for CDK2/cyclin A, shows 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM). Learn More
  49. FMF-04-159-2

    Catalog No. A18911
    Quick View
    CDK14 inhibitor
    FMF-04-159-2 is a covalent CDK14 inhibitor. FMF-04-159-2 inhibits CDK14 and CDK2 with IC50s of 39.6 nM and 256 nM in NanoBRET assay, respectively. Learn More
  50. THAL-SNS-032

    Catalog No. A19088
    Quick View
    CDK9 degrader PROTAC
    THAL-SNS-032 is a selective CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN). Learn More

Items 1 to 50 of 97 total

per page
Page:
  1. 1
  2. 2

Set Descending Direction
Rewards